Cargando…

Immune consequences of anti-angiogenic therapyin renal cell carcinoma

Current therapies of renal cell carcinoma (RCC), a highly vascularised tumour, mostly rely on anti-angiogenic treatment options. These include tyrosine kinase inhibitors (TKIs) and anti-VEGF monoclonal antibodies. Although these strategies aim at restraining vascularisation to control tumour growth,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brodaczewska, Klaudia K., Szczylik, Cezary, Kieda, Claudine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885083/ https://www.ncbi.nlm.nih.gov/pubmed/29628789 http://dx.doi.org/10.5114/wo.2018.73878

Ejemplares similares

Hypoxia-Mediated Decrease of Ovarian Cancer Cells Reaction to Treatment: Significance for Chemo- and Immunotherapies
por: Klemba, Aleksandra, et al.
Publicado: (2020)

Involvement of the CB(2) cannabinoid receptor in cell growth inhibition and G0/G1 cell cycle arrest via the cannabinoid agonist WIN 55,212–2 in renal cell carcinoma
por: Khan, Mohammed I., et al.
Publicado: (2018)

Tumor Hypoxia Regulates Immune Escape/Invasion: Influence on Angiogenesis and Potential Impact of Hypoxic Biomarkers on Cancer Therapies
por: Abou Khouzam, Raefa, et al.
Publicado: (2021)

Choosing the right cell line for renal cell cancer research
por: Brodaczewska, Klaudia K., et al.
Publicado: (2016)

Hypoxic 3D in vitro culture models reveal distinct resistance processes to TKIs in renal cancer cells
por: Bielecka, Zofia F., et al.
Publicado: (2017)

Colony, hanging drop, and methylcellulose three dimensional hypoxic growth optimization of renal cell carcinoma cell lines
por: Matak, Damian, et al.
Publicado: (2017)

Endothelial Cells as Tools to Model Tissue Microenvironment in Hypoxia-Dependent Pathologies
por: Majewska, Aleksandra, et al.
Publicado: (2021)

Right ventricular myocardial oxygen tension is reduced in monocrotaline-induced pulmonary hypertension in the rat and restored by myo-inositol trispyrophosphate
por: Oknińska, Marta, et al.
Publicado: (2021)

Distinctive Properties of Endothelial Cells from Tumor and Normal Tissue in Human Breast Cancer
por: Wilkus, Kinga, et al.
Publicado: (2021)

Functional significance of CD105-positive cells in papillary renal cell carcinoma
por: Matak, Damian, et al.
Publicado: (2017)

Metastatic renal cell carcinoma cells growing in 3D on poly-D-lysine or laminin present a stem-like phenotype and drug resistance
por: Brodaczewska, Klaudia K., et al.
Publicado: (2019)

The Role of Hypoxia and Cancer Stem Cells in Renal Cell Carcinoma Pathogenesis
por: Myszczyszyn, Adam, et al.
Publicado: (2015)

Spheroid Culture Differentially Affects Cancer Cell Sensitivity to Drugs in Melanoma and RCC Models
por: Filipiak-Duliban, Aleksandra, et al.
Publicado: (2022)

Comparative Gene Expression Profiling of Primary and Metastatic Renal Cell Carcinoma Stem Cell-Like Cancer Cells
por: Khan, Mohammed I., et al.
Publicado: (2016)

Development of extracellular matrix supported 3D culture of renal cancer cells and renal cancer stem cells
por: Maliszewska-Olejniczak, Kamila, et al.
Publicado: (2018)

Microenvironment commits breast tumor ECs to dedifferentiation by micro-RNA-200-b-3p regulation and extracellular matrix remodeling
por: Wilkus-Adamczyk, Kinga, et al.
Publicado: (2023)

Pten knockout affects drug resistance differently in melanoma and kidney cancer
por: Brodaczewska, Klaudia, et al.
Publicado: (2023)

miRNA Pattern in Hypoxic Microenvironment of Kidney Cancer—Role of PTEN
por: Majewska, Aleksandra, et al.
Publicado: (2022)

Surface markers of cancer stem-like cells of ovarian cancer and their clinical relevance
por: Klemba, Aleksandra, et al.
Publicado: (2018)

Seeking new prognostic and predictive factors in patients with metastatic renal cell carcinoma – apoptosis-regulating factors
por: Młot, Beata, et al.
Publicado: (2012)

Seeking new prognostic and predictive factors in patients with metastatic renal cell carcinoma – hypoxia-induced factors
por: Młot, Beata, et al.
Publicado: (2012)

Hypoxia, but Not Normoxia, Reduces Effects of Resveratrol on Cisplatin Treatment in A2780 Ovarian Cancer Cells: A Challenge for Resveratrol Use in Anticancer Adjuvant Cisplatin Therapy
por: Synowiec, Agnieszka, et al.
Publicado: (2023)

Tumour angiogenesis normalized by myo‐inositol trispyrophosphate alleviates hypoxia in the microenvironment and promotes antitumor immune response
por: El Hafny‐Rahbi, Bouchra, et al.
Publicado: (2021)

Renal cell carcinoma with intramyocardial metastases
por: Czarnecka, Anna M, et al.
Publicado: (2014)

Combinations of Anti-Angiogenic Agents and Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Best Option?
por: Granet-Vaissiere, Estelle, et al.
Publicado: (2023)

Current approaches in identification and isolation of human renal cell carcinoma cancer stem cells
por: Khan, Mohammed I., et al.
Publicado: (2015)

Axitinib in sequential therapy in metastatic renal cell carcinoma
por: Kuchar, Agata, et al.
Publicado: (2016)

Genomic Analysis as the First Step toward Personalized Treatment in Renal Cell Carcinoma
por: Bielecka, Zofia Felicja, et al.
Publicado: (2014)

Treatment of hypoxia‐dependent cardiovascular diseases by myo‐inositol trispyrophosphate (ITPP)‐enhancement of oxygen delivery by red blood cells
por: Oknińska, Marta, et al.
Publicado: (2020)

Pazopanib in Patients with Clear-Cell Renal Cell Carcinoma: Seeking the Right Patient
por: Porta, Camillo, et al.
Publicado: (2017)

Insulin-like growth factor-1 signaling in renal cell carcinoma
por: Tracz, Adam F., et al.
Publicado: (2016)

Culture in embryonic kidney serum and xeno-free media as renal cell carcinoma and renal cell carcinoma cancer stem cells research model
por: Krawczyk, Krzysztof M., et al.
Publicado: (2018)

Thyroid Hormones as Renal Cell Cancer Regulators
por: Szymański, Łukasz, et al.
Publicado: (2016)

Malignant tumors in patients with end stage renal failure undergoing renal replacement therapy
por: Kade, Grzegorz, et al.
Publicado: (2012)

Chromophobe renal cell cancer - review of the literature and potential methods of treating metastatic disease
por: Stec, Rafał, et al.
Publicado: (2009)

Renin angiotensin system deregulation as renal cancer risk factor
por: Sobczuk, Paweł, et al.
Publicado: (2017)

Influence of Tyrosine Kinase Inhibitors on Hypertension and Nephrotoxicity in Metastatic Renal Cell Cancer Patients
por: Semeniuk-Wojtaś, Aleksandra, et al.
Publicado: (2016)

Mechanisms of Acquired Resistance to Tyrosine Kinase Inhibitors in  Clear - Cell Renal Cell Carcinoma (ccRCC)
por: Bielecka, Zofia F., et al.
Publicado: (2013)

Mammalian Target of Rapamycin Inhibitors Resistance Mechanisms in Clear Cell Renal Cell Carcinoma
por: Kornakiewicz, Anna, et al.
Publicado: (2013)

Biomarkers defining probability of receiving second-line targeted therapy in metastatic renal cell carcinoma
por: Chrom, Pawel, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rtsd712afm7t7samv1aa17lqv2